Joshua Beilke

4.1k total citations · 2 hit papers
30 papers, 3.2k citations indexed

About

Joshua Beilke is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Joshua Beilke has authored 30 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 13 papers in Surgery and 8 papers in Genetics. Recurrent topics in Joshua Beilke's work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (19 papers) and Pancreatic function and diabetes (11 papers). Joshua Beilke is often cited by papers focused on Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (19 papers) and Pancreatic function and diabetes (11 papers). Joshua Beilke collaborates with scholars based in United States, Canada and Australia. Joshua Beilke's co-authors include Lewis L. Lanier, Joseph C. Sun, Ronald G. Gill, Natalie Bezman, Sharline Madera, Mark H. Kaplan, Luc Van Kaer, Mark R. Nicolls, Marilyne Coulombe and George S. Eisenbarth and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Joshua Beilke

30 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adaptive immune features of natural killer cells

2009 1.2k citations Joseph C. Sun, Joshua Beilke et al. Nature profile →
Opportunities for Treg cell therapy for the treatment of human disease

2023 70 citations Jeffrey A. Bluestone, Brent S. McKenzie et al. Frontiers in Immunology profile →

Peers

Countries citing papers authored by Joshua Beilke

Since Specialization

Citations

This map shows the geographic impact of Joshua Beilke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Beilke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Beilke more than expected).

Fields of papers citing papers by Joshua Beilke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Beilke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Beilke. The network helps show where Joshua Beilke may publish in the future.

Co-authorship network of co-authors of Joshua Beilke

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Beilke. A scholar is included among the top collaborators of Joshua Beilke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Beilke. Joshua Beilke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Opportunities for Treg cell therapy for the treatment of human disease breakdown → 2023 ·Frontiers in Immunology ·Jeffrey A. Bluestone, Brent S. McKenzie, Joshua Beilke, Fred Ramsdell	70
2	Integrative network modeling reveals mechanisms underlying T cell exhaustion 2020 ·Scientific Reports ·Hamid Bolouri, Mary H. Young, Joshua Beilke, Rebecca Johnson, Brian A. Fox, Lu Huang, (unknown), Christopher M. Hill, Anne-Renée Van der Vuurst de Vries, Paul Shannon, Andrew Dervan, Pallavur V. Sivakumar, Matthew Trotter, Douglas E. Bassett, Alexander V. Ratushny	16
3	Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide 2016 ·The Journal of Experimental Medicine ·Sharline Madera, Moritz Rapp, Matthew A. Firth, Joshua Beilke, Lewis L. Lanier, Joseph C. Sun	154
4	Proinflammatory cytokine signaling required for the generation of natural killer cell memory 2012 ·The Journal of Experimental Medicine ·Joseph C. Sun, Sharline Madera, Natalie Bezman, Joshua Beilke, Mark H. Kaplan, Lewis L. Lanier	242
5	NK Cells Are Not Required for Spontaneous Autoimmune Diabetes in NOD Mice 2012 ·PLoS ONE ·Joshua Beilke, Craig Meagher, (unknown), Marine Champsaur, Jeffrey A. Bluestone, Lewis L. Lanier	17
6	Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection 2011 ·Journal of Clinical Investigation ·Xinguo Jiang, Mohammad Afzal Khan, Wen Tian, Joshua Beilke, Ramesh Natarajan, Jon C. Kosek, Mervin C. Yöder, Gregg L. Semenza, Mark R. Nicolls	89
7	Immune memory redefined: characterizing the longevity of natural killer cells 2010 ·Immunological Reviews ·Joseph C. Sun, Joshua Beilke, Lewis L. Lanier	92
8	The requirement for NKG2D in NK cell–mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient 2010 ·Blood ·Joshua Beilke, Jonathan Benjamin, Lewis L. Lanier	20
9	Redox Modulation Protects Islets From Transplant-Related Injury 2010 ·Diabetes ·(unknown), Suzanne Bertera, Hubert M. Tse, Rita Bottino, Jing He, Joshua Beilke, Marilyne Coulombe, Ronald G. Gill, James D. Crapo, Massimo Trucco, Jon D. Piganelli	58
10	Adaptive Immune Features of Natural Killer Cells (44.1) 2009 ·The Journal of Immunology ·Joseph C. Sun, Joshua Beilke, Lewis L. Lanier	21
11	Adaptive immune features of natural killer cells breakdown → 2009 ·Nature ·Joseph C. Sun, Joshua Beilke, Lewis L. Lanier	1199
12	“Indirect” Acute Islet Allograft Destruction in Nonobese Diabetic Mice Is Independent of Donor Major Histocompatibility Complex and Requires Host B Lymphocytes 2008 ·Transplantation Proceedings ·(unknown), Joshua Beilke, Kim Pham, (unknown), Ronald G. Gill	4
13	Frontiers in Nephrology 2007 ·Journal of the American Society of Nephrology ·Joshua Beilke, Ronald G. Gill	23
14	Priming and effector dependence on insulin B:9–23 peptide in NOD islet autoimmunity 2007 ·Journal of Clinical Investigation ·Maki Nakayama, Joshua Beilke, Jean Jasinski, Masakazu Kobayashi, Dongmei Miao, Marcella Li, Marilyne Coulombe, Edwin Liu, John F. Elliott, Ronald G. Gill, George S. Eisenbarth	95
15	NK cells promote islet allograft tolerance via a perforin-dependent mechanism 2005 ·Nature Medicine ·Joshua Beilke, (unknown), Luc Van Kaer, Ronald G. Gill	155
16	Increased NF‐κB activity in B cells and bone marrow‐derived dendritic cells from NOD mice 2004 ·European Journal of Immunology ·William H. Wheat, (unknown), (unknown), Gina R. Rayat, Joshua Beilke, Robert I. Scheinman, Dale R. Wegmann	45
17	A major role for host MHC class I antigen presentation for promoting islet allograft survival 2004 ·Transplantation Proceedings ·Joshua Beilke, (unknown), (unknown), Ronald G. Gill	6
18	Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse 2003 ·Proceedings of the National Academy of Sciences ·Hiroaki Moriyama, Norio Abiru, Johanna Paronen, (unknown), Edwin Liu, Dongmei Miao, Devasenan Devendra, Joshua Beilke, Roberto Gianani, Ronald G. Gill, George S. Eisenbarth	162
19	CD4-Dependent Generation of Dominant Transplantation Tolerance Induced by Simultaneous Perturbation of CD154 and LFA-1 Pathways 2002 ·The Journal of Immunology ·Mark R. Nicolls, Marilyne Coulombe, Joshua Beilke, H. Carl Gelhaus, Ronald G. Gill	77
20	Interferon-?? is not a universal requirement for islet allograft survival1 2002 ·Transplantation ·Mark R. Nicolls, Marilyne Coulombe, (unknown), Joshua Beilke, Ronald G. Gill	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact